Fundamental Data for VNUS

VNUS Medical Technologies provides medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition caused by incompetent vein valves in the leg. VNUS sells the Closure system, which consists of a proprietary radio-frequency, or RF, generator and proprietary disposable endovenous catheters to close diseased veins through the application of temperature-controlled RF energy.

# Employees: 318

Address: ,,,

Phone:

Fax:

Website:

Email:

Sector: Medical

Industry: MED PRODUCTS

Executive Officers

No Information

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 3/31/2009

Next Earnings Date(Expected): 7/28/2009

Mean EPS (Next Qtr): $0.14

Mean EPS (Year): $0.65

Mean Estimate(Long Term): $48.33

P/E Ratio(Based on EPS estimate): 44.650

Number of Estimates: 6

Shares Performance

Period	VNUS	Compare to S&P
YTD	78.48 %	70.38 %
4 Weeks	0.66 %	-6.08 %
12 Weeks	40.19 %	13.87 %

Shares Information

Analyst Coverage: Y

Avg Volume: 293527

Shares Outstanding: 16M

Market Cap: $0.47B

52 Week High: $28.98

52 Week Low: $12.33

P/E Ratio: 30.470

PEG Ratio: 0.920

Split: On 1/1/1990 VNUS split by factor of 0.100

Earnings Performance

EPS Growth in Last Quarter: -61.90 %

EPS Growth in Last Year: 366.67 %

Sales Growth in Last Quarter: -9.25 %

Sales Growth in Last Quarter: 30.87 %

Financials

Qtr Book Value: $4.84

Cash Flow/Share: $30.92

Change in Payout Ratio: 0.000

Price/Sales: 4.390